MX9308002A - Soluciones mejoradas de aminoacidos para dialisis peritoneal. - Google Patents

Soluciones mejoradas de aminoacidos para dialisis peritoneal.

Info

Publication number
MX9308002A
MX9308002A MX9308002A MX9308002A MX9308002A MX 9308002 A MX9308002 A MX 9308002A MX 9308002 A MX9308002 A MX 9308002A MX 9308002 A MX9308002 A MX 9308002A MX 9308002 A MX9308002 A MX 9308002A
Authority
MX
Mexico
Prior art keywords
amino acid
peritoneal dialysis
acid solutions
improved amino
improved
Prior art date
Application number
MX9308002A
Other languages
English (en)
Inventor
Leo Martis
Michael R Jones
Original Assignee
Baxter Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Baxter Int filed Critical Baxter Int
Publication of MX9308002A publication Critical patent/MX9308002A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A61K33/10—Carbonates; Bicarbonates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/14—Alkali metal chlorides; Alkaline earth metal chlorides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/14—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
    • A61M1/28—Peritoneal dialysis ; Other peritoneal treatment, e.g. oxygenation
    • A61M1/287—Dialysates therefor

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • External Artificial Organs (AREA)
  • Medicinal Preparation (AREA)

Abstract

La presente invención proporciona una solución de diálisis que contienen aminoácidos para tratar y/o prevenir la malnutrición o desnutrición en un paciente con diálisis peritoneal. La composición de aminoácidos se optimiza para minimizar la acidosis metabólica, mientras que se normalizan los niveles del perfil de aminoácidos en el plasma.
MX9308002A 1992-12-22 1993-12-15 Soluciones mejoradas de aminoacidos para dialisis peritoneal. MX9308002A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US99585592A 1992-12-22 1992-12-22

Publications (1)

Publication Number Publication Date
MX9308002A true MX9308002A (es) 1994-08-31

Family

ID=25542284

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9308002A MX9308002A (es) 1992-12-22 1993-12-15 Soluciones mejoradas de aminoacidos para dialisis peritoneal.

Country Status (14)

Country Link
US (3) US5670176A (es)
EP (1) EP0626845B1 (es)
JP (1) JP3483885B2 (es)
KR (1) KR100309972B1 (es)
AT (1) ATE226433T1 (es)
AU (1) AU678201B2 (es)
CA (1) CA2129998C (es)
DE (1) DE69332433T2 (es)
DK (1) DK0626845T3 (es)
ES (1) ES2185646T3 (es)
MX (1) MX9308002A (es)
NZ (1) NZ259242A (es)
SG (1) SG48704A1 (es)
WO (1) WO1994014430A1 (es)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2723690B1 (fr) * 1994-08-17 1996-09-27 Seb Sa Appareil de chauffe pour aliments, en particulier pour la realisation de fritures, comportant une contre-cuve
JPH1171273A (ja) * 1997-08-29 1999-03-16 Terumo Corp 腹膜透析液
WO1999034813A1 (en) * 1998-01-05 1999-07-15 Johns Hopkins University Supplement for dialysis patients
EP0970699B1 (en) * 1998-07-07 2005-09-07 Terumo Kabushiki Kaisha Peritoneal dialysis solution
US8105258B2 (en) * 1999-04-26 2012-01-31 Baxter International Inc. Citrate anticoagulation system for extracorporeal blood treatments
DE60039978D1 (de) 1999-04-26 2008-10-02 Edwards Lifesciences Ag Substitutions-infusionflüssigkeit und zitratanticoagulation
US7186420B2 (en) * 1999-04-26 2007-03-06 Edwards Lifesciences Corporation Multi-part substitution infusion fluids and matching anticoagulants
US6830692B1 (en) * 1999-09-20 2004-12-14 Degussa Ag Amino acid composition for hemodialysis
US6787039B2 (en) * 2001-01-26 2004-09-07 Degussa Ag Amino acid composition for hemodialysis
JP2002275059A (ja) * 2001-03-15 2002-09-25 Inst Of Physical & Chemical Res 腎機能障害改善用アミノ酸組成物
ITTO20020672A1 (it) * 2002-07-26 2004-01-26 Medestea Res And Production S Composizioni farmaceutiche contenenti cheto-acidi per somministrazione endoperitoneale
US20050148647A1 (en) * 2003-10-31 2005-07-07 Landry Donald W. Hemodialysis solutions and uses thereof
CN100417380C (zh) * 2005-12-14 2008-09-10 于力犁 透析液用氨基酸粉/液、其复合透析液粉/液及制备方法
US7972615B2 (en) * 2008-03-27 2011-07-05 Affinergy, Inc. Peptide compositions for coating metal medical devices with vancomycin
CN102370640A (zh) * 2010-08-18 2012-03-14 俞黎黎 血液透析用复方氨基酸制剂及含复方氨基酸的血液透析用制剂
EP2489408A1 (de) 2011-01-13 2012-08-22 Michael Tchirikov Aminosäurezusammensetzung und deren Verwendung zur Behandlung von fetaler Wachstumsrestriktion (IUGR) und zur parenteralen Ernährung von extrem Frühgeborenen
CN105640947A (zh) * 2014-11-10 2016-06-08 天津金耀集团有限公司 碱性必需氨基酸乳酸盐腹膜透析液药物组合物
CN105640948A (zh) * 2014-11-10 2016-06-08 天津金耀集团有限公司 必需氨基酸乳酸盐腹膜透析液药物组合物
CN105640945A (zh) * 2014-11-10 2016-06-08 天津金耀集团有限公司 低钙必需氨基酸腹膜透析液药物组合物
CN105640946A (zh) * 2014-11-10 2016-06-08 天津金耀集团有限公司 氨基酸（15）乳酸盐腹膜透析液药物组合物
CN105560275A (zh) * 2014-11-10 2016-05-11 天津金耀集团有限公司 碱性低钙必需氨基酸腹膜透析液药物组合物
RS60268B1 (sr) * 2014-12-04 2020-06-30 Professional Dietetics Int S R L In Forma Abbreviata P D Int S R L Aminokiselinska struktura za obnovu fibroelastina u dermalnim vezujućim tkivima
US10973251B1 (en) 2015-09-21 2021-04-13 The Board Of Trustees Of The Leland Stanford Junior University Nutritional treatment for cancer
US10342824B2 (en) 2017-07-17 2019-07-09 Dr. Marlowe's Weight Loss Institute, P.L.L.C. Supplement for treating side effects of medications which cause metabolic acidosis
AU2018383715A1 (en) * 2017-12-11 2020-06-18 Filtricine, Inc. Compositions, methods, kits and systems for cancer treatment and metabolic intervention therapy

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0077354A4 (en) * 1981-04-27 1983-09-30 Baxter Travenol Lab DIALYSIS SOLUTION CONTAINING GLUCOSE, AMINO ACIDS AND INSULIN.
US4357343A (en) * 1981-06-26 1982-11-02 Baxter Travenol Laboratories, Inc. Nutritional composition for management of renal failure
CA1239586A (en) * 1984-10-02 1988-07-26 Dimitrios G. Oreopoulos Dialysis solution containing amino acids
DE3821043A1 (de) * 1988-06-22 1989-12-28 Fresenius Ag Dialysier- und spuel-loesung zur intraperitonealen verabreichung
DE3843289A1 (de) * 1988-12-22 1990-06-28 Diehl Gmbh & Co Treibspiegelmunition
EP0555087B1 (en) * 1992-02-04 1998-08-05 Baxter International Inc. Peritoneal dialysis solutions containing at least one dipeptide
US5589197A (en) * 1993-10-04 1996-12-31 Baxter International, Inc. Low sodium peritoneal dialysis solution

Also Published As

Publication number Publication date
KR950700059A (ko) 1995-01-16
EP0626845B1 (en) 2002-10-23
ES2185646T3 (es) 2003-05-01
WO1994014430A1 (en) 1994-07-07
SG48704A1 (en) 1998-05-18
DE69332433D1 (de) 2002-11-28
JPH07504210A (ja) 1995-05-11
US5670176A (en) 1997-09-23
AU678201B2 (en) 1997-05-22
DE69332433T2 (de) 2003-08-14
KR100309972B1 (ko) 2001-12-28
JP3483885B2 (ja) 2004-01-06
CA2129998C (en) 2006-07-11
NZ259242A (en) 1997-03-24
EP0626845A1 (en) 1994-12-07
DK0626845T3 (da) 2003-02-17
AU5748894A (en) 1994-07-19
US5698230A (en) 1997-12-16
ATE226433T1 (de) 2002-11-15
US5776503A (en) 1998-07-07
CA2129998A1 (en) 1994-07-07

Similar Documents

Publication Publication Date Title
MX9308002A (es) Soluciones mejoradas de aminoacidos para dialisis peritoneal.
US4593044B1 (es)
IL81030A0 (en) Aqueous solutions containing organic anions,for fluid therapy
BR9506021A (pt) Solução de diálise peritoneal e processo para corrigir a acidose metabólica
AU2161888A (en) Anti-acne composition
ATE201597T1 (de) Verabreichung von riluzol zur behandlung von neuro-aids
BR9713653B1 (pt) composiÇço farmacÊutica, mÉtodo para preparar uma composiÇço farmacÊutica, e, uso de pirofosfato fÉrrico.
DK0626857T3 (da) Forbedrede peritoneale dialyseopløsninger med polypeptider
DE3463385D1 (en) Compounds for treating hypertension
AU1777595A (en) Methods for treating neurofibromatosis
JPS56128711A (en) Glucose-electrolyte preparation for high-calorie transfusion
FR2366248A1 (fr) Procede de purification de phenols
AU8043587A (en) Process for the recovery of acid organophosphorus compounds and/or organophosphate ions present in an aqueous solution and its use for the treatment of aqueous effluents
DE3772107D1 (de) Pharmazeutische zubereitung fuer orale verabreichung von eisensalzen, verwendbar zur behandlung von anaemien durch eisenmangel.
NO942013L (no) Litiumsalt av 2-0-alkylaskorbinsyre
JPS6466130A (en) High polymer carcinostatic enhancer
NZ336662A (en) Treatment of mania and bipolar disorder with gabapentin
ATE193537T1 (de) Phosphorylierte derivate von verbindungen mit antiinflammatorischen oder analgetischer wirkung
ES2069499A1 (es) Procedimiento de envasado de compuestos y concentrados para utilizar en el tratamiento de la dialisis y hemodialisis.
ATE190837T1 (de) Aminosäureergänzung
UA8280A (uk) Спосіб лікування псоріазу
UA19325A (uk) Спосіб одержаhhя аhіоhітової мембраhи
TH17660EX (th) สารผสมสำหรับป้องกันและรักษาสายตาสั้น
BG94567A (en) Medicaments for the treatment of aids and method for its application
UA31672A (uk) Спосіб лікування хворих на сепсис

Legal Events

Date Code Title Description
FG Grant or registration
MM Annulment or lapse due to non-payment of fees